Skip to main content
GalvanizeFunding round

Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation

What happened

Galvanize Therapeutics closed an oversubscribed $130 million Series D financing round led by HealthQuest Capital.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

HealthQuest Capital leads financing to support Aliya commercial expansion, clinical evidence generation, pipeline advancement, and development of next-generation pulsed electric field ablation platforms REDWOOD CITY, Calif., Nov. 16, 2026 /PRNewswire/ -- Galvanize Therapeutics ® , a commercial-stage company pioneering pulsed electric field (PEF) ablation technologies for oncology and chronic disease, today announced the closing of an oversubscribed $130 million Series D financing. The round was

prnewswire.com/news-releases/galvanize-therapeutics-raises-130-millio...Read the full source

Extracted by Autobound

From the Signal API record
Event
Funding round

What this signalsNew funding often brings new budget and vendor reviews.

Amount
$130M
Takes effect
Nov 16, 2026
Location
Redwood City, California, United States
Round
Series D
Financing type
Equity

Companies

  • HealthQuest CapitalInvestorhealthquestcapital.com

More from Galvanize

The full record

From the Signal API record

Numbers

Amount (USD)
$130M

Extraction

Confidence
95%
Detected
Nov 16, 2026
signal_type
news
signal_subtype
receives_financing

Use this data

Get every funding round signal for Galvanize and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galvanize this week?”

  2. Send it to your own tools

    The Signal API returns funding round signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6c2cbe0c-5d5b-f1d7-a797-3cb77dbf039b returns this record as JSON. POST /v1/companies/enrich returns every signal for galvanizetx.com.

{
  "signal_id": "6c2cbe0c-5d5b-f1d7-a797-3cb77dbf039b",
  "signal_type": "news",
  "signal_subtype": "receives_financing",
  "detected_at": "2026-11-16T13:00:00+00:00",
  "company": {
    "name": "Galvanize",
    "domain": "galvanizetx.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/galvanize-therapeutics-raises-130-million-in-oversubscribed-series-d-financing-to-accelerate-commercial-growth-and-advance-pef-innovation-302939618.html",
    "title": "Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation - PR Newswire",
    "excerpt": "HealthQuest Capital leads financing to support Aliya commercial expansion, clinical evidence generation, pipeline advancement, and development of next-generation pulsed electric field ablation platforms REDWOOD CITY, Calif. , Nov. 16, 2026 /PRNewswire/ -- Galvanize Therapeutics ® , a commercial-stage company pioneering pulsed electric field (PEF) ablation technologies for oncology and chronic disease, today announced the closing of an oversubscribed $130 million Series D financing. The round was",
    "summary": "Galvanize Therapeutics closed an oversubscribed $130 million Series D financing round led by HealthQuest Capital.",
    "location": "Redwood City, California, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS1378046/Galvanize-Logo.jpg?id=OA3063962&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-11-16T13:00:00Z",
    "location_data": [
      {
        "city": "Redwood City",
        "state": "California",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-16",
    "article_sentence": "Galvanize Therapeutics ® , a commercial-stage company pioneering pulsed electric field (PEF) ablation technologies for oncology and chronic disease, today announced the closing of an oversubscribed $130 million Series D financing.",
    "amount_normalized": 130000000,
    "financing_type_tags": [
      "equity"
    ],
    "related_company_name": "HealthQuest Capital",
    "related_company_domain": "healthquestcapital.com",
    "financing_type_normalized": "series_d"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.